Search Results - "Keyaerts M"

Therapeutically Engineering Exosomes to Target CD206+ M2 Macrophages to Prevent the Development of Primary Tumors and Distal Metastases in Breast Cancers.

Authors: Parvin, Mahrima Alptekin, Ahmet Kashif, Sawaiz et al.

Source: Cancers. May2026, Vol. 18 Issue 10, p1619. 29p.

Development and Evaluation of "a PEGylated Anti-Tau ScFv for SPECT Imaging" in a Rat Model of Traumatic Brain Injury.

Authors: Sajjadi, Esmat Sharif-Paghaleh, Ehsan Akrami, Mohammad et al.

Source: Pharmaceutics. May2026, Vol. 18 Issue 5, p626. 19p.

Prognostic Value of 18 F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab.

Authors: Kocaaslan, Erkam Güren, Ali Kaan Akagündüz, Fırat et al.

Source: Journal of Clinical Medicine. Jan2026, Vol. 15 Issue 2, p798. 13p.

Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma.

Authors: Martínez-Vila, Clara Teixido, Cristina Martín, Roberto et al.

Source: Cancers. Dec2025, Vol. 17 Issue 23, p3804. 15p.

BANTAM-01: A Multicenter, Open-Label, First-in-Human Phase 1 Dose Escalation and Expansion Study of ²²⁵Ac-GPC3 (BAY 3547926) in Patients with Advanced Hepatocellular Carcinoma.

Authors: Tjeertes, Jorrit Dostalek, Miroslav Glaus, Charles et al.

Source: Journal of Nuclear Medicine. Mar2026, Vol. 67 Issue 3, p360-365. 6p.

Author Index.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2012 Supplement, Vol. 39, p640-682. 43p.

AUTHOR INDEX.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2008 Supplement 2, Vol. 35, p407-435. 29p.

Tiny tools closing the gap: nanobodies in research and therapy.

Authors: Abdellatif, Mustafa Rajurkar, Jyotirmoy Leonhardt, Heinrich

Source: Function. Apr2026, Vol. 7 Issue 2, p1-20. 20p.

[⁶⁸Ga]Ga-HER2 Affibody PET/CT for early prediction of neoadjuvant therapy outcome in HER2-positive breast cancer: a preliminary report.

Authors: Sun, Yuhan An, Ran Yang, Ruoxi et al.

Source: EJNMMI Research. 4/2/2026, Vol. 16 Issue 1, p1-12. 12p.

Relationship between absorbed dose and SUV derived from SPECT/CT imaging and dose-response in patients with neuroendocrine tumors treated with [¹⁷⁷Lu]Lu-DOTA-TATE.

Authors: Liu, Fei Yang, Hongxing Zhang, Jianping et al.

Source: EJNMMI Research. 2/25/2026, Vol. 16 Issue 1, p1-12. 12p.

[⁶⁸Ga]Ga-NOTA-T4 ImmunoPET imaging for evaluating TROP2 expression in patients with solid tumors.

Authors: Jiang, Donglang Chu, Zhaohui Wu, Yanfei et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2025, Vol. 52 Issue 12, p4547-4557. 11p.

Advances in liver, liver lesion, hepatic vasculature, and biliary segmentation: a comprehensive review of traditional and deep learning approaches.

Authors: Sethia, Khyati Strakos, Petr Jaros, Milan et al.

Source: Artificial Intelligence Review; Oct2025, Vol. 58 Issue 10, p1-95, 95p

Author index.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jun2005 Supplement, Vol. 32, pS297-S318. 21p.

Virtual cutaneous area severity index (vCASI): A comprehensive methodology for quantitative skin disease assessment on positron emission tomography images.

Authors: Mortazi, Aliasghar Udupa, Jayaram K. Hosseini, Mahdie et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Dec2025, Vol. 53 Issue 1, p295-305. 11p.

Toward Personalized Response Monitoring in Melanoma Patients Treated with Immunotherapy and Target Therapy.

Authors: Venturi, Federico Magnaterra, Elisabetta Gualandi, Alberto et al.

Source: Diagnostics (2075-4418). Dec2025, Vol. 15 Issue 23, p3054. 19p.

Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors.

Authors: Larkina, Mariia Yanovich, Gleb Hasnowo, Lutfi Aditya et al.

Source: International Journal of Molecular Sciences. Nov2025, Vol. 26 Issue 21, p10609. 22p.

Rapid cleavage of 6-[¹⁸F]fluoronicotinic acid prosthetic group governs BT12 glioblastoma xenograft uptake: implications for radiolabeling design of biomolecules.

Authors: Dillemuth, Pyry Ayo, Abiodun Zhuang, Xiaoqing et al.

Source: EJNMMI Radiopharmacy & Chemistry. 7/8/2025, Vol. 10 Issue 1, p1-15. 15p.

Using [ 18 F]FDG PET/CT to Identify Optimal Responders to Neoadjuvant Therapy in Breast Cancer—Results from a Prospective Patient Cohort.

Authors: Gelardi, Fabrizia Tiberio, Paola Torrisi, Rosalba et al.

Source: Cancers. Jul2025, Vol. 17 Issue 13, p2133. 12p.

Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

Authors: Toyohara, Jun Vugts, Danielle Kiss, Oliver C. et al.

Source: EJNMMI Radiopharmacy & Chemistry. 5/16/2024, Vol. 9 Issue 1, p1-20. 20p.

Antibody–drug conjugates for infectious and neglected tropical diseases: chemical design principles, target biology, and translational challenges.

Authors: Reddy, Desigan Jeena, Vineet Papo, Tshephiso R. et al.

Source: Frontiers in Chemistry. 2026, p1-33. 33p.